Professional Documents
Culture Documents
Defined Anaerobic Growth Medium For Studying Candida Albicans Basic Biology and Resistance To Eight Antifungal Drugs
Defined Anaerobic Growth Medium For Studying Candida Albicans Basic Biology and Resistance To Eight Antifungal Drugs
7-1-2004
Jacob M. Hornby
University of Nebraska-Lincoln, jmhornby@lcsc.edu
Kenneth W. Nickerson
University of Nebraska-Lincoln, knickerson1@unl.edu
Dumitru, Raluca; Hornby, Jacob M.; and Nickerson, Kenneth W., "Defined Anaerobic Growth Medium for
Studying Candida albicans Basic Biology and Resistance to Eight Antifungal Drugs" (2004). Papers in
Microbiology. 44.
https://digitalcommons.unl.edu/bioscimicro/44
This Article is brought to you for free and open access by the Papers in the Biological Sciences at
DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Papers in Microbiology by an
authorized administrator of DigitalCommons@University of Nebraska - Lincoln.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, July 2004, p. 2350–2354 Vol. 48, No. 7
0066-4804/04/$08.00⫹0 DOI: 10.1128/AAC.48.7.2350–2354.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
The polymorphic fungus Candida albicans is one of the most versatile opportunistic pathogens in humans.
Many organs of the human body are potential targets for infection by this pathogen, but infection is commonly
localized in the gastrointestinal tract, an environment providing anaerobic growth conditions. We describe a
chemically defined anaerobic growth medium for four strains of Candida albicans (A72, SC5314, MEN, and
10261). It is a defined liquid glucose-phosphate-proline growth medium supplemented with oleic acid, nicotinic
The dimorphic fungus Candida albicans is one of the most to-anaerobic adaptation of indeterminate length. To gauge the
commonly isolated fungal pathogens in humans. Infections likely duration of an aerobic-to-anaerobic adaptive period, we
with C. albicans, called candidoses, occur predominantly in note that when grown anaerobically, the yeast Saccharomyces
immunosuppressed patients (AIDS, cancer treatment, and cerevisiae requires ergosterol as an added growth factor (1).
transplant patients). For AIDS patients, candidosis has been However, when an aerobically grown culture of S. cerevisiae is
shown to be the most common human immunodeficiency virus- inoculated into anaerobic medium that does not contain er-
associated opportunistic infection (19). C. albicans is also as- gosterol, growth stops only after five to seven generations (27).
sociated with 78% of fungal nosocomial infections and over This comparative lack of interest in anaerobic growth is
10% of all nosocomial infections documented (19). The annual surprising for two reasons. First, in many cases C. albicans in-
cost of treating candidal infections in the United States has fections spread into the body from the anaerobic gastrointes-
been estimated at 1 billion dollars (22). tinal tract (19, 25), and second, the interiors of many biofilms
The aerobic growth of C. albicans has been studied exten- are anaerobic (9). Furthermore, the accurate assessment of an
sively, but even though C. albicans has often been referred to organism’s nutritional requirements requires the use of chem-
as a facultative anaerobe (25), papers describing anaerobic ically defined media, and reproducible anaerobically grown
growth are rare. Our literature search recovered only eight inocula require liquid media. We now describe a minimal de-
articles (10, 16, 17, 33, 35–38), two of which (16, 33) describe fined liquid medium for the anaerobic growth of C. albicans,
survival under anaerobic conditions rather than actual anaer- consisting of a glucose-phosphate-proline (GPP) medium (13,
obic growth and three more of which (10, 17, 38) merely 18) supplemented with oleic acid, nicotinic acid, and ammo-
confirm that anaerobic growth is possible. However, Szawat- nium chloride.
kowski and Hamilton-Miller (35) reported that 20 strains of Effective antifungal antibiotics are rare due to few fungus-
C. albicans could grow anaerobically on either Sabouraud agar
specific targets and the rapid development of drug resistance.
or brucella agar supplemented with 10% whole horse blood,
Research has been done to test the sensitivity and resistance of
and Webster and Odds (37) showed that seven Candida spe-
C. albicans cells grown aerobically (21, 32) and anaerobically
cies, including C. albicans, could grow anaerobically on four
(35, 36, 38) to several antifungal agents. We have tested five
media: Eagle’s minimal medium with 10% horse serum, a
classes of antifungal agents on cells grown anaerobically: poly-
peptone-glucose broth, and two defined but complicated me-
enes, allylamines, azoles, zaragozic acid B, and cerulenin. Poly-
dia (yeast nitrogen base-glucose broth and yeast nitrogen base-
enes, such as amphotericin B, bind to ergosterol present in the
asparagine-glucose-phosphate [YAGP] broth). However, in all
cell membrane, causing damage to the cell membrane and
cases the experiments were conducted with aerobically grown
leakage of intracellular ions (31). Azoles such as fluconazole,
inocula and GasPak anaerobic systems. Thus, the experiments
studied both steady-state anaerobic conditions and an aerobic- ketoconazole, voriconazole, and itraconazole block ergosterol
biosynthesis by inhibiting the cytochrome P450 responsible for
14␣ demethylation of lanosterol (31). Additionally, the allyl-
* Corresponding author. Mailing address: School of Biological Sci- amine terbinafine inhibits squalene epoxidase (31), zaragozic
ences, University of Nebraska, Lincoln, NE 68588-0666. Phone: (402)
acid B inhibits squalene synthase (14), and cerulenin inhibits
472-2253. Fax: (402) 472-8722. E-mail: knickerson1@unl.edu.
† Present address: Division of Natural Sciences, Lewis-Clark State fatty acid synthesis (26). We found that anaerobically grown
College, Lewiston, ID 83501. cells were at least fourfold more resistant than aerobically
2350
VOL. 48, 2004 ANAEROBIC GROWTH OF CANDIDA ALBICANS 2351
anaerobically grown inoculum, the cells remained ca. 95% for aerobic growth and an anaerobic inoculum for anaerobic
mycelial throughout growth at 25, 30, and 37°C. growth. We also employed a crossover design in which both
It is well known that under aerobic conditions germ tubes or aerobic and anaerobic inocula were used for both aerobic and
hyphae are triggered at 37°C by either L-proline, serum, or anaerobic growth. The crossover design was used to test for
N-acetyl-D-glucosamine (13, 25). Consequently, we wondered miconazole sensitivity. Since the same medium was used for all
whether the L-proline in our complete defined anaerobic me- these experiments, the presence or absence of oxygen was the
dium was necessary for the production of mycelia. It was not. only variable. With both inocula, the MIC of miconazole was 4
Equivalent percentages of mycelia were observed when L-pro- g/ml during aerobic growth and ⬎80 g/ml during anaerobic
line was replaced with either L-arginine or L-phenylalanine, growth.
although in both cases the growth rates were somewhat lower The morphology of the cells growing anaerobically in the
(data not shown). presence of 4 to 16 g of amphotericin B, fluconazole, keto-
Farnesol. We next investigated whether anaerobically grown conazole, zaragozic acid B, and cerulenin per ml was the same
C. albicans cells either produced farnesol or responded to as that of cells growing in the absence of these agents. Mycelia
exogenous farnesol. They did neither. When examined by our were present continuously. This observation is in contrast to
standard gas chromatography-mass spectrometry detection what was observed for aerobic C. albicans, with which subin-
system (13), no extracellular farnesol was detected in superna- hibitory concentrations of the azole antifungals inhibit mycelial
tants from cells which had been grown anaerobically at 30°C development and maintain the cells in the yeast morphology
for 4 to 5 days. That is, there was less than 0.001 g of farnesol (12, 25). This morphological conversion is likely due to the
per mg (dry weight) of cells. In contrast, aerobically grown cells secretion of excess farnesol by azole-treated C. albicans (15).
produce ca. 0.18 to 0.22 g of farnesol/mg (15). Furthermore, However, for sublethal levels of terbinafine, the anaerobic cells
during anaerobic growth, C. albicans did not respond to far- grew as yeast cells; the mycelial form was inhibited.
nesol. In complete defined medium with farnesol present from Physiological versus genetic. Stationary-phase anaerobically
time zero, the cell growth rates and morphologies remained grown cells were diluted and counted as CFU on yeast extract-
unchanged, with farnesol concentrations ranging from 0 to 1.2
mM. The same results occurred at both 30 and 37°C and with
both aerobically and anaerobically grown inocula. In particu- TABLE 1. Inhibitory concentrations of cell inhibitors and
lar, the kinetics for the yeast-to-mycelium conversion of an antifungal compounds for aerobically and anaerobically
aerobically grown inoculum were the same with and without grown C. albicans A72
farnesol. This concentration of farnesol (1.2 mM) represents Inhibitory concn (g/ml)a
Compound
the maximum solubility of farnesol in water. In contrast, aer- Aerobic growth Anaerobic growth
obic C. albicans exhibits a 50% conversion of mycelia to yeast
cells at only 1.2 M farnesol (34). Amphotericin B 0.5 ⬎20 (not reached)
Cerulenin 1 4
Antifungals. Our studies revealed that anaerobically grown Terbinafine 4 32
cells were much more resistant than aerobically grown cells Zaragozic acid B 0.5 8
to eight antifungals. Anaerobically grown C. albicans was re- Clotrimazole 2 ⬎16 (not reached)
sistant to all concentrations of amphotericin B, clotrimazole, Fluconazole 8 ⬎40 (not reached)
fluconazole, miconazole, and ketoconazole (Table 1). Also, Miconazole 4 ⬎16 (not reached)
Ketoconazole 4 ⬎4 (not reached)
anaerobically grown cells were 4, 8, and 16 times more resistant
a
than aerobically grown cells to cerulenin, terbinafine, and zara- Concentration at which no growth was evident after 48 h (aerobic) or 5 days
(anaerobic). C. albicans A72 grown anaerobically appeared to be resistant to
gozic acid B, respectively (Table 1). The experimental design amphotericin B and the four azole antifungals, in that the cells still grew at the
whose results are shown in Table 1 used an aerobic inoculum highest concentrations tested.
VOL. 48, 2004 ANAEROBIC GROWTH OF CANDIDA ALBICANS 2353
peptone-dextrose agar. Ten colonies were picked at random anaerobic medium in the absence of sterols, growth stops only
and grown aerobically in unsupplemented GPP medium. All 10 after five to seven generations (27).
strains were equally as sensitive to fluconazole as the starting Added nutritional requirements for the anaerobic growth of
C. albicans strain, which had never been grown anaerobically. fungi are well known. Anaerobically, S. cerevisiae requires both
Therefore, the antibiotic resistance shown in Table 1 is not due ergosterol (1) and an unsaturated fatty acid, usually oleic acid
to selection for antibiotic-resistant mutants. (2), while Mucor rouxii requires nicotinic acid (6). We have
added to this list by finding that C. albicans requires both oleic
acid and nicotinic acid. Recognition of these added nutritional
DISCUSSION
requirements for C. albicans provides further confirmation that
We have devised a defined liquid medium for the anaerobic the conditions employed were indeed anaerobic.
growth of C. albicans. It consists of the GPP medium that we An understanding of nutritional requirements should also
use for the aerobic growth of C. albicans (13) supplemented prove useful in interpreting physiological aspects of anaerobic
with oleic acid, nicotinic acid, and ammonium chloride. Ergos- growth. For instance, Webster and Odds (37) noted marked
terol is not required. All anaerobic protocols used the Hungate differences in the cell yields for anaerobically grown C. albi-
technique for stringently growing anaerobes (7). Anaerobic cans. For the four media they studied (Eagle’s minimal me-
crepancy is created; for instance, mice infected with a certain 12. Ha, K. C., and T. C. White. 1999. Effects of azole antifungal drugs on the
transition from yeast cells to hyphae in susceptible and resistant isolates of
strain of C. albicans responded to fluconazole therapy despite the pathogenic yeast Candida albicans. Antimicrob. Agents Chemother. 43:
the fact that in vitro testing indicated that the strain was not 763–768.
susceptible to fluconazole (30). One cause of the trailing 13. Hornby, J. M., E. C. Jensen, A. D. Lisec, J. J. Tasto, B. Jahnke, R. Shoe-
maker, P. Dussault, and K. W. Nickerson. 2001. Quorum sensing in the
growth phenotype may be anaerobic growth in the automated dimorphic fungus Candida albicans is mediated by farnesol. Appl. Environ.
microtiter plates in which the in vitro susceptibility measure- Microbiol. 67:2982–2992.
ments were made. The geometry of the individual wells would 14. Hornby, J. M., B. W. Kebaara, and K. W. Nickerson. 2003. Farnesol biosyn-
thesis in Candida albicans: cellular response to sterol inhibition by zaragozic
make it difficult to achieve adequate aeration. Repeating the in acid B. Antimicrob. Agents Chemother. 47:2366–2369.
vitro-in vivo comparison with fully aerated cultures should 15. Hornby, J. M., and K. W. Nickerson. 2004. Enhanced production of farnesol
by Candida albicans treated with four azoles. Antimicrob. Agents Che-
resolve this dilemma. Second, C. albicans cells exhibit greater mother. 48:2305–2307.
resistance to fluconazole and other antifungal drugs when they 16. Kaminishi, H., A. Iwata, T. Tamaki, T. Cho, and Y. Hagihara. 1994. Spiral
are in biofilms than when they are not (3, 20, 23). However, the hyphae of Candida albicans formed in anaerobic culture. Mycoses 37:349–
352.
interiors of many microbial biofilms are highly anaerobic (9), 17. Kot, E. J., V. L. Olson, L. J. Rolewic, and D. O. McClary. 1976. An alternate
and at least three features of C. albicans biofilms could be respiratory pathway in Candida albicans. Antonie Leeuwenhoek 42:33–48.
explained if their interiors were anaerobic or partially anaer- 18. Kulkarni, R. K., and K. W. Nickerson. 1981. Nutritional control of dimor-
phism in Ceratocystis ulmi. Exp. Mycol. 5:148–154.